AlgireG. H.ChalkleyH. W.: Vascular reactions of normal and malignant tissues in vivo. I. Vascular reaction of mice to wounds and to normal neoplastic transplants. J. nat. Cancer Inst.6 (1945), 73.
2.
AlgireG. H.ChalkleyH. W.LegallaisF. V.: Recent developments in the transparent-chamber technique as adapted to the mouse. J. Nat. Cancer Inst.10 (1949), 225.
3.
AlgireG. H.ChalkleyH. W., Vascular reactions of normal and malignant tissues in vivo. IV. The effect of peripheral hypotension on transplanted tumours. J. nat. Cancer Inst.12 (1951), 399.
BiermanH. R.ByronR. L.KellyK. H.GradyA.: Studies on the blood supply of tumours in man. III. Vascular patterns of the liver by hepatic arteriography in vivo. J. nat. Cancer Inst.12 (1951), 107.
6.
BiermanH. R.ByronR. L.KellyK. H.GradyA.GilfillanR. S.KellyK. H. et coll.: Studies on the blood supply of tumours in man. V. Skin temperatures of superficial neoplastic lesions. J. nat. Cancer Inst.13 (1952), 1.
7.
BiermanH. R.ByronR. L.KellyK. H.GradyA.KellyK. H.DodK. S. et coll.: Studies on the blood supply of tumours in man. I. Fluorescence of cutaneous lesions. J. nat. Cancer Inst.11 (1951), 87.
8.
SingerG. J.: Studies in the blood supply of tumours in man. IV. The increased oxygen content of venous blood draining neoplasms. J. nat. Cancer Inst.12 (1952), 701.
9.
BlaschkoH.: Biological inactivation of 5-hydroxytryptamine. In: 5-hydroxytryptamine. See p. 52. Editor: LewisG. P.Pergamon Press, Oxford1957.
10.
CaterD. B.: The carcinogenic action of carrageenin in rats. Brit. J. Cancer15 (1961), 607.
11.
CaterD. B.GarattiniS.MarinaF.SilverI. A.: Changes in oxygen tension in brain and somatic tissues induced by vasodilator and vasoconstrictor drugs. Proc. Roy. Soc. B.155 (1961), 136.
12.
CaterD. B.PhillipsA. F.SilverI. A.(a): Apparatus and techniques for the measurement of oxidation-reduction potentials, pH and oxygen tension in vivo. Proc. Roy. Soc. B.146 (1957), 289.
13.
CaterD. B.(b): The measurement of oxidation-reduction potentials, pH, and oxygen tension in tumours. Proc. Roy. Soc. B.146 (1957), 382.
14.
CaterD. B.(c): Induced changes in oxidation-reduction potentials, pH, and oxygen tension in the intact lactating mammary gland. Proc. Roy. Soc. B.146 (1957), 400.
15.
CaterD. B.SilverI. A.: Quantitative measurements of oxygen tension in normal tissues and in the tumour of patients before and after radiotherapy. Acta radiol.53 (1960), 233.
16.
CaterD. B., Microelectrodes and electrodes used in biology. In: Reference electrodes. See pp 503–515. Editors: IvesD. J. G.JanzG. J.Academic Press, New York1961.
17.
CaterD. B.WilsonG. M.: Apparatus and techniques for the quantitative measurement of oxygen tension in living tissues. Proc. Roy. Soc. B.151 (1959), 256.
18.
Churchill-DavidsonI.SangerC.ThomlinsonR. H.: Oxygenation in radiotherapy: clinical application. Brit. J. Radiol.30 (1957), 406.
19.
ComvaliusN.: Serotonin for conditioning of the animal host. Surg. Forum11 (1960), 68.
20.
CrossB. A.SilverI. A.: Personal communication (1961).
21.
DanneelH.: Über den durch diffundierende Gase hervorgerufenen Reststrom. Z. Elektrochem.4 (1897–8), 227.
22.
EwingJ.: General pathology — Blood vessels. In: Neoplastic diseases p. 57. Third edit. Saunders, Philadelphia1928.
23.
GoldacreR. J.SylvénB.: A rapid method for studying tumour blood supplies with systemic dyes. Nature184 (1959), 63.
24.
GoldmannE.: The growth of malignant disease in man and the lower animals, with special reference to the vascular system. Proc. Roy. Soc. Med. Surgical section (1908), 1.
25.
GrayL. H.: Oxygenation in radiotherapy. 1. Radiobiological considerations. Brit. J. Radiol.30 (1957), 403.
26.
HorwitzH.McCGregg D.MarrianD. H. et coll.: Clinical and laboratory studies of the therapeutic possibilities of tritiated Synkavit, mainly by intra-arterial administration. Acta radiol. (1959) Suppl. 188, p. 111.
27.
HultbornK. A.ForssbergA.: Irradiation of skin tumours during pure oxygen inhalation. Acta radiol.42 (1954), 475.
28.
IdeA. G.BakerN. H.WarrenS. L.: Vascularisation of the Brown-Pearce rabbit epithelioma transplant as seen in the transparent ear chamber. Amer. J. Roentgenol.42 (1939), 891.
29.
KernG.ZanderJ.: Gefässveränderungen im Verlauf der carcinogenese Lebendbeobachtungen am Ohr der Maus nach Pinselung mit Methylycholanthren. Z. Krebsforsch.63 (1959), 168.
30.
LangendorffH.MelchingH-J.LadnerH-A.: Untersuchungen über einen biologischen Strahlenschutz. XXX. Mitteilung: Über die Strahlenschutzwirkung des 5-Hydroxytryptamin im Tierversuch. Strahlentherapie108 (1959), 251.
31.
LangendorffH.MelchingH-J.LadnerH-A.Untersuchungen über einen biologischen Strahlenschutz. XXXI. Mitteilung: Zum Wirkungsmechanismus des 5-Hydroxytryptamin im Strahlenschutzversuch. Strahlentherapie109 (1959), 554.
32.
LewisW. H.: The vascular pattern of tumours. Johns Hopk. Hosp. Bull.41 (1927), 156.
33.
van der MeerC.van BekkumD. W.: The mechanism of radiation protection by histamine and other biological amines. Int. J. Rad. Biol.1 (1959), 5.
34.
MitchellJ. S.(a): Clinical trials of radiosensitizers. Combination of oxygen inhaled at atmospheric pressure, Synkavit and X-ray therapy. Animal experiments. A. R. Brit. Emp. Cancer Campaign35 (1957), 267, 269, 270.
35.
MitchellJ. S.(b): Some clinical and laboratory studies of chemical radiosensitizers. Acta Un. int. Cancr.13 (1957), 450.
36.
MitchellJ. S.Some clinical and laboratory studies of chemical radiosensitizers, including the design and conduct of clinical trials. In: Studies in radiotherapeutics, pp. 80–165. Blackwell Scientific Publications, Oxford1960.
37.
NatadzeT. G.: Regulation of blood circulation in malignant tumours. Vop. Onkol5 (1959), 654.
38.
OwenL. N.: A rapid method for studying tumour blood supply using lissamine green. Nature187 (1960), 795.
39.
ParrattJ. R.WestG. B.: 5-hydroxytryptamine and the anaphylactoid reaction in the rat. J. Physiol.139 (1957), 27.
40.
RileyJ. F.: The mast cell reaction in precancerous skin of mice. In: The mast cells, p. 152. Livingstone, Edinburgh1959.
41.
RowleyD. A.BendittE. P.: 5-Hydroxytryptamine and histamine as mediators of the vascular injury produced by agents which damage mast cells in rats. J. exp. Med.103 (1956), 399.
42.
dos SantosR.: Arteriography in bone tumours. J. Bone Jt. Surg.32 B (1950), 1, 17.
43.
ScottK. G.StoneR. S.: The anti-tumour action of lysergic acid derivatives and their serotonin-blocking effect as reflected by the I131 distribution in rats. Cancer Res.19 (1959), 783.
44.
ScottK. G.StoneR. S.SchelineR. R.StoneR. S.: Mast cells and sarcoma growth in rat cancer research. Cancer Res.18 (1958), 927.
45.
SilverI. A.CaterD. B.MarrianD. H.MarshallB.: The use of tritiated tetra-sodium 2-methyl- 1: 4-naphthaquinol diphosphate for the treatment of spontaneous tumours in animals. Acta radiol.58 (1962), 281.
46.
ThierschC.: Der Epithelialkrebs namentlich der Haut mit Atlas. Leipzig (1865).
47.
UdenfriendS.WeissbachH.BogdanskiD. F.: Increase in tissue serotonin following administration of its precursor 5-Hydroxytryptophan. J. Biol. Chem.224 (1957), 803.
48.
YoungJ. S.LumsdenC. E.StalkerA. L.: Significance of ‘tissue pressure’ of normal testicular and neoplastic (Brown-Pearce carcinoma) tissue in rabbit. J. Path. Bact.62 (1950), 313.